) found) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2023 Reviewed Company Q3 30/11/2022 2023 Reviewed Consolidated Q3 30/11/2022 2023 Reviewed
Year 31/10/2022 2022 Consolidated Year 31/10/2022 2022 Reviewed Company Q3 31/07/2022 2022 Reviewed Consolidated Q3 31/07/2022 2022 Reviewed Company Q2 30/04/2022 2022
Company Q3 30/11/2024 2025 Reviewed Consolidated Q3 30/11/2024 2025 Reviewed Consolidated Q2 31/08/2024 2025 Reviewed Company Q2 31/08/2024 2025 Reviewed Consolidated Q1 31/05/2024
Comparison is as follows: THB’000 Consolidated ∆% Separate ∆% 2017 2016 2017 2016 REVENUES FROM SALES AND SERVICES 2,473,795 3,672,528 -33% 1,631,566 1,812,983 -10% Interest income 1,045 1,896 -45% 36,148
follows: THB’000 Consolidated ∆% Separate ∆% 2017 2016 2017 2016 REVENUES FROM SALES AND SERVICES 2,473,795 3,672,528 -33% 1,631,566 1,812,983 -10% Interest income 1,045 1,896 -45% 36,148 21,274 70
P a g e 1 | 7 Management Discussion and Analysis For the nine-month period ended September 30, 2017 The analysis of consolidated financial position as at 30 September 2017 The group’s assets
P a g e 1 | 8 Management Discussion and Analysis For the nine-month period ended September 30, 2017 The analysis of consolidated financial position as at 30 September 2017 The group’s assets
According to the resolution of the meeting of the Board of Directors No. 6/2017 of Rajthanee Hospital Public Company Limited (the “Company”) held on 10 November 2017, approving the reviewed consolidated
, export branded sales continued to grow significantly from sales recognition of Long Quan Safe Food JSC (LQSF) in Vietnam. After all, sales have bottomed out from Q3/2018, growing 8% QoQ with growth in